563 related articles for article (PubMed ID: 29376469)
21. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
Du Y; Liu X; Liang Q; Liang XJ; Tian J
Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
[TBL] [Abstract][Full Text] [Related]
22. Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate.
Nowicka AM; Kowalczyk A; Jarzebinska A; Donten M; Krysinski P; Stojek Z; Augustin E; Mazerska Z
Biomacromolecules; 2013 Mar; 14(3):828-33. PubMed ID: 23327587
[TBL] [Abstract][Full Text] [Related]
23. Magnetic nanoparticles: a novel platform for cancer theranostics.
Singh A; Sahoo SK
Drug Discov Today; 2014 Apr; 19(4):474-81. PubMed ID: 24140592
[TBL] [Abstract][Full Text] [Related]
24. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
25. Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia.
Wang C; Hsu CH; Li Z; Hwang LP; Lin YC; Chou PT; Lin YY
Int J Nanomedicine; 2017; 12():6273-6287. PubMed ID: 28894366
[TBL] [Abstract][Full Text] [Related]
26. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications.
Amiri M; Salavati-Niasari M; Akbari A
Adv Colloid Interface Sci; 2019 Mar; 265():29-44. PubMed ID: 30711796
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer.
Li Y; Xin J; Sun Y; Han T; Zhang H; An F
Cancer Biol Med; 2020 May; 17(2):307-327. PubMed ID: 32587771
[TBL] [Abstract][Full Text] [Related]
28. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
Chen B; Wu W; Wang X
Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
[TBL] [Abstract][Full Text] [Related]
29. Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.
Zakaria MB; Belik AA; Liu CH; Hsieh HY; Liao YT; Malgras V; Yamauchi Y; Wu KC
Chem Asian J; 2015 Jul; 10(7):1457-62. PubMed ID: 25944287
[TBL] [Abstract][Full Text] [Related]
30. Thermal potentiation of chemotherapy by magnetic nanoparticles.
Torres-Lugo M; Rinaldi C
Nanomedicine (Lond); 2013 Oct; 8(10):1689-707. PubMed ID: 24074390
[TBL] [Abstract][Full Text] [Related]
31. Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy.
Martinkova P; Brtnicky M; Kynicky J; Pohanka M
Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29205944
[TBL] [Abstract][Full Text] [Related]
32. Magnetic nanoformulations for prostate cancer.
Chowdhury P; Roberts AM; Khan S; Hafeez BB; Chauhan SC; Jaggi M; Yallapu MM
Drug Discov Today; 2017 Aug; 22(8):1233-1241. PubMed ID: 28526660
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor (EGF) fragment-guided anticancer theranostic particles for pH-responsive release of doxorubicin.
Kang MK; Mao W; Lee JB; Yoo HS
Int J Pharm; 2017 Mar; 519(1-2):104-112. PubMed ID: 28087384
[TBL] [Abstract][Full Text] [Related]
34. Magnetic Nanoparticles: A Review on Stratagems of Fabrication an d its Biomedical Applications.
Srivastava P; Sharma PK; Muheem A; Warsi MH
Recent Pat Drug Deliv Formul; 2017; 11(2):101-113. PubMed ID: 28355997
[TBL] [Abstract][Full Text] [Related]
35. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
Jiao Y; Sun Y; Tang X; Ren Q; Yang W
Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
Li L; Liu H
Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
[No Abstract] [Full Text] [Related]
37. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
[TBL] [Abstract][Full Text] [Related]
39. Magnetic nanoparticles in nanomedicine: a review of recent advances.
Wu K; Su D; Liu J; Saha R; Wang JP
Nanotechnology; 2019 Dec; 30(50):502003. PubMed ID: 31491782
[TBL] [Abstract][Full Text] [Related]
40. Iron Oxide Nanoparticles for Breast Cancer Theranostics.
Shakil MS; Hasan MA; Sarker SR
Curr Drug Metab; 2019; 20(6):446-456. PubMed ID: 30465497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
